Hypoxia is a salient feature of most solid tumors, and hypoxic adaptation of cancer cells has crucial implications in propagation of malignant clonal cell population. Osteopontin (OPN) has been identified as a hypoxia-responsive gene, but the mechanistic and regulatory role of OPN under hypoxia is less characterized. The present study identifies the existence of a positive inter-regulatory loop between hypoxia and OPN. We have shown that hypoxia induces OPN expression in breast cancer cells; however, the expression was found to be HIF1a independent. OPN enabled transcriptional upregulation of HIF1a expression both under normoxia and hypoxia, whereas stability of HIF1a protein in breast cancer cells remained unaffected. Moreover, we have shown that OPN induces integrin-linked kinase (ILK)/Akt-mediated nuclear factor (NF)-kB p65 activation leading to HIF1a-dependent vascular endothelial growth factor (VEGF) expression and angiogenesis in response to hypoxia. These in vitro data are biologically important as OPN expressing cells induce greater tumor growth and angiogenesis through enhanced expressions of proangiogenic molecules as compared with control. Immunohistochemical analysis of human breast cancer specimens revealed significant correlation between OPN and HIF1a but not HIF2a. Elevated expression of HIF1a and OPN was observed in pre-neoplastic and early stage infiltrating ductal carcinoma implicating the role of these proteins in neoplastic progression of breast cancer. Together, our results substantiate the prime role of OPN in cellular adaptation through ILK and NF-kB-mediated HIF1a-dependent VEGF expression in response to hypoxia that ultimately controls breast cancer progression and angiogenesis. Our study reinforces the fact that targeting OPN and its regulated signaling network hold important therapeutic implications.
INTRODUCTION
Rapid cellular proliferation and perfused blood vessels within solid tumors result in an oxygen gradient commonly referred to as hypoxia. Several studies have reported that hypoxia exerts critical selection pressure on cancer cells that leads to clonal expansion of highly malignant cells. [1] [2] [3] Cellular adaptation to hypoxia is therefore imperative for cancer cell survival, and this coordinated homeostatic response to hypoxia is largely mediated through activation of several genes namely HIF1 and HIF2 that facilitates short-term or long term adaptive mechanisms. [4] [5] [6] HIF1 is a heterodimeric transcription factor comprising of oxygen-sensitive alpha sub-unit and the constitutively expressed beta sub-unit. 7 Under normoxia, HIF1a is hydroxylated at key proline residues, leading to von Hippel-Lindau protein binding and ubiquitination which is followed by its degradation via 26 S proteosome pathway. Proline hydroxylation is inhibited under hypoxia resulting in a stabilized alpha sub-unit which then translocates to the nucleus and heterodimerizes with the b subunit and binds to conserved DNA sequence known as hypoxiaresponsive element on the promoters of target genes. [8] [9] [10] HIF1a regulates a wide array of genes involved in tumor angiogenesis, chemoresistance and metastasis. 11 HIF1a is found to be overexpressed in several cancers and is indicative of poor prognosis in lymph node-negative breast cancer patients. [12] [13] [14] Increased metastatic risk was associated with breast cancer patients with p0 2 o10 mm Hg. 15 Recent studies reveal that HIF1a can be selectively regulated at the levels of transcription, translation and post-translation by several growth factors. [16] [17] [18] However, the study on distinct molecular mechanisms involved in the selective regulation of HIF1a in breast cancer is not well defined.
Osteopontin (OPN) is a phosphoglyco protein that facilitates cell-matrix interactions and has been implicated in multiple aspects of tumor progression. [19] [20] [21] [22] [23] Increased serum levels of OPN have been associated with enhanced metastatic burden and poor disease outcome in patients. [24] [25] [26] OPN is a diagnostic marker in hepatocellular, cervical and head and neck carcinoma. 27 OPN has been reported to instigate indolent tumor growth through bone marrow activation. 28 Elevated plasma OPN levels in head and neck cancer patients were indicative of poor patient outcome and also correlated with tumor hypoxia. 29, 30 OPN is known to confer cancer cell resistance to hypoxia and reoxygenation-induced cell death. 31, 32 Hypoxia enhances avb 3 integrin expression in B16F10 cells and also silencing avb 3 or avb 5 integrins results in decreased HIF1a expression in glioma. 33, 34 Integrin-linked kinase (ILK) is closely associated with integrin signaling and has been reported to have a pivotal role in hypoxia-induced tumor angiogenesis.
Here we report that hypoxia-induced OPN is required for maximal expression of HIF1a in breast cancer cells. OPN modulates HIF1a expression at transcriptional level via ILKand Akt-dependent nuclear factor (NF)-kB p65 signaling axis. Collectively our results delineate the role of OPN under hypoxia and its implication in breast tumor growth and angiogenesis through NF-kB-mediated HIF1a-dependent vascular endothelial growth factor (VEGF) expression.
RESULTS

Hypoxia-induced OPN enhances accumulation of HIF1a
Previous reports have shown that NIH 3T3 cells upon exposure to hypoxia upregulate OPN expression, and OPN has been reported to elevate HIF1a expression in gastric cancer cells. 29, 36 Recent report also documents the influence of OPN and HIF1a expression on radiosensitivity of breast cancer cells. 37 But the molecular mechanism by which these molecules regulate breast cancer progression and angiogenesis under hypoxia remains unexplored. Firstly, we examined the effect of hypoxia on OPN expression in breast cancer cells, and the results indicated that hypoxia induces OPN expression in both MDA-MB-231( Figure 1a ) and MCF-7 cells (Supplementary Figures S1a and b) . Adaptation of cells to oxygen-depleted conditions is essential to their survival and primarily depends on the expression of effector molecules, such as HIF1a and HIF2a. To assess the probable role of OPN on HIF's regulation under hypoxic conditions, MDA-MB-231 cells were transiently transfected with siRNA specific to OPN or b 3 integrin, and the expression levels of HIF1a, HIF1b and HIF2a were determined. The results revealed that upon silencing either OPN or b 3 integrin, HIF1a expression was found to be diminished, whereas HIF1b and HIF2a expression levels remained unaltered (Figure 1b ). The slightly elevated basal level of HIF1a observed in MDA-MB-231 cells is in accord with previous reports. 38 The results were consistent in MCF-7 cells as decreased HIF1a, but not HIF1b, level was observed upon silencing of OPN or b 3 integrin (Supplementary Figure S1c) . The silencing efficiency of OPN and b 3 integrin in siRNA-transfected cells was confirmed by western blot (Supplementary Figure S1d) . To further verify the contribution of OPN on HIF1a induction, OPN knockout (KO)-derived mouse embryonic fibroblast (MEF) cells were subjected to hypoxia and the HIF1a expression was analyzed at both protein and RNA levels; the results indicated that OPN is indeed involved in hypoxiainduced HIF1a expression (Figures 1c and d) (Figure 1e ). To determine whether the effect observed on HIF1a is a direct consequence of altered OPN levels, we supplemented OPN KO-derived MEF cells with WTconditioned media and found that HIF1a expression was restored. This was abrogated in the presence of OPN-neutralizing antibody that suggests that OPN regulates HIF1a expression (Figure 1f ). OPN expression in OPN KO-derived MEF was determined by reverse transcriptase-PCR (RT-PCR) and treated as control (Supplementary Figure S1e) .
Previous studies have shown that pro-inflammatory cytokines like tumor necrosis factor a regulates HIF1a expression under normoxia. 40 Therefore, we sought to determine whether OPN regulates HIF1a expression in breast cancer cells under normoxic conditions. Accordingly, MDA-MB-231 or MCF-7 cells were independently treated with increasing concentrations of purified OPN (0-1 mM), and HIF1a was analyzed by western blot. The results revealed that OPN upregulates HIF1a expression under normoxic conditions in a dose-dependent manner (Figure 2a, left and right) . Similarly, MCF-7 cells were treated with increasing doses of rhOPN (recombinant human OPN), exposed with hypoxia and HIF1a expression was analyzed by western blot. The results revealed that OPN treatment increased HIF1a expression under hypoxia (Supplementary Figure S1f) .
Various cytokines or growth factors have been shown to regulate HIF1a expression by influencing transcriptional, translational as well as hydroxylation status of this protein. 41, 42 Hydroxylation of HIF1a at P564 and P402 residue is essential for von Hippel-Lindau mediated degradation. 43 We have shown the effect of OPN on HIF1a transcription, and as the function of HIF1a is tightly regulated through its hydroxylation, we explored the possibility of effect of OPN on HIF1a hydroxylation. MCF-7 or MCF-7 cells stably transfected with OPN cDNA (MCF-OPN-a) were exposed to either normoxia or hypoxia for 16 h and OH-HIF1a (P564) was detected by western blot. The results revealed that both MCF-7 and MCF-OPN-a cells under hypoxia had decreased hydroxylation of HIF1a as compared with normoxic condition (Figure 2b ). This is because hydroxylation of HIF1a (P564) is attenuated under hypoxic condition, and OPN enhanced HIF1a expression leading to elevated OH-HIF1a levels under normoxic condition. To identify whether OPN has any effect on stability of HIF1a, MCF-7 or MCF-OPN-a cells were pretreated with 100 mM CoCl 2 for 3 h and then treated with cycloheximide for 0-60 min and HIF1a and OPN expression levels were determined. The results suggested that the stability of HIF1a is independent of OPN expression ( Figure 2c ). As there was no significant alteration of HIF1a stability or hydroxylation in response to OPN in MCF-7 cells, we suggest that the effect of OPN on HIF1a expression was strictly regulated at the transcriptional level.
The level of OPN in MCF-OPN-a cells was analyzed by RT-PCR and western blot ( Figure 2d ). We also found elevated HIF1a expression and nuclear translocation in MCF-OPN-a cells exposed to hypoxia as compared with control ( Figure 2e ). To investigate the possibility of reciprocal loop between HIF1a and OPN, MDA-MB-231 cells were treated with 150 mM deferrioxamine for 0-16 h and expression levels of OPN as well as HIF1a were examined by western blot. The data indicated that deferrioxamine treatment significantly enhanced HIF1a but not OPN expression, clearly suggesting that hypoxia upregulates OPN in a HIF1a-independent manner (Figure 2f ).
OPN enhances hypoxia-induced phosphatidylinositol 3
0 -kinase (PI3K)/ILK-dependent Akt activation Several lines of evidences have shown the involvement of either PI3K or MAP kinase in regulation of HIF1a expression. 44, 45 To identify the signaling intermediates involved in OPN-mediated HIF1a regulation, MCF-7 or MCF-OPN-a cells were subjected to hypoxia. In separate experiments, MCF-OPN-a cells were pretreated with either LY294002 or PD98059, exposed with hypoxia and analyzed for HIF1a expression by RT-PCR. The results revealed that PI3K inhibitor but not MAPK inhibitor attenuated OPN-induced HIF1a transcription under hypoxic conditions ( Figure 2g ). Previous studies have shown that inhibition of ILK suppresses activation of Akt and induces cell-cycle arrest and apoptosis in PTEN-mutant prostate cancer cells. 46 It has been also demonstrated that ILK has an important role in HIF1a-and VEGF-dependent tumor angiogenesis in prostate cancer model. 47 ILK acts as PI3K-dependent effector of integrinmediated cell signaling and upstream regulator of Akt. and LY294002. These data suggested that OPN enhances hypoxia-induced PI3K-dependent ILK and Akt activation in breast cancer cells.
NF-kB has crucial role in OPN-mediated HIF1a regulation under hypoxia NF-kB activation under hypoxia and its cross talk with HIF1a signaling pathways are well documented. 48 NF-kB activation by tumor necrosis factor a is reported to regulate HIF1a expression. 49 The crucial interplay between these molecules under hypoxia is not well defined. In this study, the role of NF-kB p65 in OPN-mediated HIF1a regulation under hypoxic conditions was examined, and the data indicated that hypoxia-induced ILK/Aktdependent p65 phosphorylation was further enhanced in MCF-OPN-a as compared with MCF-7 cells (Figure 3c ). In separate experiments, MCF-OPN-a cells were pretreated with either LY294002 or transiently transfected with siRNA specific to ILK or p65 and p-p65 level was analyzed by western blot and the data suggested that both ILK and PI3K are involved in OPN-induced p65 activation in response to hypoxia (Figure 3c) . The active involvement of NF-kB in regulation of HIF1a under hypoxia was confirmed as silencing p65 or its upstream signaling molecules significantly inhibited OPN-induced HIF1a expression under hypoxia (Figure 3d ). The proteasomal inhibitor, MG-132, was used to check the effect of OPN on HIF1a degradation (Figure 3d) . To further examine the specificity of effect of OPN on hypoxia-induced Akt and p65 phosphorylation and HIF1a and VEGF expression, MDA-MB-231 cells were stably transfected with OPN shRNA and the levels of p-Akt, p-p65 and HIF1a were analyzed. The data indicated that MDA-MB-231 cells stably transfected with OPN shRNA reduced the expressions of p-Akt, p-p65, HIF1a and VEGF in response to hypoxia (Supplementary Figures S2a and b) . The silencing of OPN in MDA-MB-231-OPN shRNA was determined by western blot (Supplementary Figure S2c) . These results demonstrated that OPN regulates ILK/Akt-mediated p65-dependent HIF1a expression in response to hypoxia in breast cancer cells.
OPN augments HIF1a-mediated angiogenic response in breast cancer cells through upregulation of VEGF expression As VEGF is a potent inducer of angiogenesis and is reported to be upregulated under hypoxia by HIF1a in several cancers, we sought to determine whether HIF1a might influence VEGF expression and VEGF-dependent angiogenesis in response to hypoxia in breast cancer cells. Briefly, MCF-7 or MCF-OPN-a cells were subjected to hypoxia and VEGF expression was determined by western blot. In separate experiments, MCF-OPN-a cells were transfected with siRNA specific to ILK, p65 or HIF1a, and VEGF expression was analyzed under hypoxic conditions. The results revealed that VEGF expression was upregulated in MCF-OPN-a cells through ILK/p65-mediated HIF1a-dependent pathway (Figure 4a ). To determine whether OPN can functionally potentiate angiogenesis in response to hypoxia, chorioallantoic membrane (CAM) assay was performed. Briefly, the conditioned media collected from MCF-7 or MCF-OPN-a cells upon hypoxia were applied onto CAM of fertilized eggs, and blood vessel growth was assessed after a period of 48 h. In separate experiments, MCF-OPN-a cells transfected with HIF1a siRNA were exposed to hypoxia or conditioned media from hypoxia exposed MCF-OPN-a cells were incubated with VEGF neutralizing antibody and CAM assay was performed. The fold changes in blood vessel length and size were analyzed and represented as bar graph. The results revealed that hypoxia-induced angiogenesis was further enhanced in the presence of OPN, but the effect was attenuated in the presence of VEGF-neutralizing antibody or HIF1a siRNA. The results suggested that OPN augments hypoxia-induced angiogenic response through HIF1a-dependent VEGF expression (Figures 4b, c and 5a ).
Hypoxia-induced breast cancer cell migration and invasion is suppressed upon silencing OPN and HIF1a Hypoxia enhances metastatic potential of breast cancer cells. in OPN-induced breast cancer cell migration under normoxic and hypoxic conditions, MDA-MB-231 cells were transiently transfected with HIF1a siRNA and then treated in the absence or presence of 0.5 mM OPN and subjected to hypoxia treatment for 16 h, and wound migration assay was performed. Similar experiments were conducted under normoxic conditions. Photographs were taken at both 0 and 16 h and area migrated by the cells were calculated, statistically analyzed and represented as bar graph. The data revealed that OPN induces MDA-MB-231 cell migration under normoxic and hypoxic conditions, but silencing HIF1a diminished OPN-induced breast cancer cell migration under hypoxia but not under normoxia (Figure 5c and Supplementary Figure S4) . In separate experiments, migration (using Boyden chamber) and invasion assay (using matrigel-coated chamber) were performed under same conditions as described in wound migration assay. The migrated or invaded cells were stained, photographed, quantified and represented in the form of bar graph. The results revealed that silencing OPN or b 3 integrin resulted in decreased migration or invasion of MDA-MB-231 cells under hypoxia (Figure 5d, Supplementary Figures S5a-c) .
Overexpression of OPN enhanced and silencing decreased breast tumor growth and angiogenesis in vivo Our in vitro results prompted us to extend the studies to mice xenograft breast tumor model. To determine the effect of OPN on breast tumor growth, MCF-7 or MCF-OPN-a cells were injected into the mammary fat pads of female nonobese diabetic/severe combined immunodeficient (NOD-SCID) mice. It has been reported that HIF1a expression is critically regulated by growth factors, and 17-b estradiol or 2-methoxy-estradiol (estradiol metabolite) negatively regulates HIF1a expression. 51, 52 Therefore, these factors were not externally supplemented in our tumorigenicity experiments. Tumor volumes were calculated and growth kinetics was plotted as tumor volume versus time in weeks and represented graphically ( Figure 6A ). At the end of 6 weeks, tumors were dissected and photographed. The tumor samples were lysed and analyzed for levels of HIF1a, OPN and VEGF by western blot. The results showed that MCF-OPN-aderived tumors showed elevated expression profiles of these proteins as compared with parental control and reaffirmed our in vitro data ( Figure 6B) . The results clearly indicated that OPN has a crucial role in breast tumor progression and enables estradiol-independent growth of MCF-7 cells in vivo. Tumor specimens were analyzed by immunohistochemistry and the results revealed that elevated expression levels of HIF1a, ILK, OPN and VEGF were observed in tumors derived from MCF-OPN-a cells (Figures 6Ca-Ch) . Furthermore, MCF-OPN-a tumors were found to be highly vascularized in comparison to parental MCF-7-derived tumors as analyzed by CD31 staining (Figures 6Ci and Cj) . In separate experiments, MDA-MB-231 or MDA-MB-231-OPN shRNA cells were injected into mammary fat pads of female NOD-SCID mice, and growth kinetics over a period of 7 weeks was calculated and graphically represented ( Figure 6D ). Tumors were excised and photographed, and tumor sections were analyzed by immunohistochemistry. The results indicated that MDA-MB-231-OPN shRNA tumor sections had decreased expression of HIF1a, VEGF and CD31 ( Figure 6D ). This clearly suggests that OPN contributes to breast tumor progression by modulating angiogenic response, which is in part mediated through HIF1a regulation.
Expression profiles of OPN and HIF1a in clinical specimens and its correlation with breast cancer progression Immunohistochemical analyses of OPN and HIF1a were performed on breast tumor specimens, and the staining was scored by oncopathologist. Statistical analysis revealed a close association between OPN and HIF1a in primary tumors. Of all the primary tumors analyzed, 75.47% (40/53) had considerable OPN expression and 63% of all the OPN-expressing tissues were co-expressing HIF1a (Supplementary Table S1 ). Expression of HIF1a and OPN was also found in preneoplastic breast ductal carcinoma in situ specimens (Figure 7a ). In addition, expression of these proteins in surrounding normal tissue was negligible, whereas benign tissues showed only weak expression (Figure 7a ). Our clinical data reaffirms the positive correlation observed between OPN and HIF1a in vitro (Table 1) . Furthermore, both OPN and HIF1a were found to be overexpressed in 60% (3/5) of post-chemotherapy breast tumor specimens (data not shown). To determine the effect of OPN on HIF2a, which is a well-known paralog of HIF1a, we analyzed HIF2a levels in MCF-OPN-a cells by confocal microscopy, and our data indicated that OPN had no effect on HIF2a expression (Supplementary Figure S6) . In addition, we have also analyzed the HIF2a levels in clinical specimens (N ¼ 19) and correlated its expression with both OPN and HIF1a (Figure 7b ). Statistical analysis revealed that HIF2a did not correlate with both OPN and HIF1a in primary tumors (Supplementary Table S2 ). Our data suggested that correlation between OPN and HIF1a is exclusive and might have crucial implications in breast cancer progression.
DISCUSSION
Hypoxia is one of the crucial determinants that regulates tumor angiogenesis and metastasis and has been often associated with metastatic burden and poor clinical outcome in breast cancer. 2, 15 In this study, we have delineated the molecular mechanism by which OPN augments hypoxia-induced angiogenic response in breast cancer cells. Previous reports have indicated an enhanced expression of OPN under hypoxia and OPN is known to confer cytoprotection against hypoxia/reoxygenation-induced apoptosis. 29, 31 Our study corroborates with these findings as we found that OPN is upregulated under hypoxic conditions. We have further characterized the molecular pathways by which OPN exerts its proangiogenic role under hypoxic condition in breast cancer cells. OPN has been reported to be associated with elevated HIF1a and MMP-9 expression levels in gastric cancer and this study further supports our in-depth findings. 36 We report that OPN upregulates HIF1a at protein and mRNA levels under hypoxia, whereas HIF1b and HIF2a levels remain unaltered. Our results suggested that OPN had no influence on HIF1a stability as well as hydroxylation, and the regulation of HIF1a expression was at the transcriptional level. In this study, using OPN KO-derived MEF cells, we have shown that lack of OPN significantly downregulated HIF1a expression under both normoxia and hypoxia. Our results also indicated that there was no reciprocal loop between HIF1a and OPN as inhibitor of HIF1a degradation (deferrioxamine) had no effect on OPN expression in breast cancer cells.
Our findings implicate ILK and Akt as signaling intermediate involved in OPN-regulated HIF1a expression under hypoxic conditions in human breast cancer cells. The results also established the role of activated NF-kB p65 in regulating HIF1a expression that is consistent with previous reports. 49 Our data substantiate the ability of OPN to potentiate hypoxia-induced HIF1a-mediated angiogenic response via VEGF upregulation. Hypoxia is a crucial factor for orchestrating cancer cell metastasis. 53 We also report that upon silencing OPN or its receptor significantly downregulates hypoxia-induced breast cancer cell migration and invasion, and HIF1a is involved in this process. Further, OPN promotes breast tumor progression predominantly through its proangiogenic response, which is in part mediated through HIF1a and VEGF. Moreover, our clinical data revealed a significant correlation between OPN and HIF1a expression in precancerous (ductal carcinoma in situ) and cancerous (invasive ductal carcinoma) lesions that further corroborated our in vitro and in vivo findings. Further analysis revealed that 60% of post-chemotherapy specimens have dual positivity for both OPN and HIF1a, implicating their role in chemoresistance which is in accordance with previous reports. 54, 55 The possibility of these proteins as potential markers for chemoresistance needs to be further examined. Our studies have revealed that HIF2a expression is not regulated by OPN in breast cancer cells, and analysis of clinical specimens also supported our in vitro finding as there were no statistically significant correlation for HIF2a expression with both HIF1a and OPN. Therefore, HIF1a and HIF2a may differentially regulate in breast cancer, and OPN regulates only HIF1a and not HIF2a under hypoxia in breast cancer cells. Our study demonstrates that OPN exclusively regulates HIF1a-dependent VEGF expression through ILK/NF-kB pathway under hypoxic conditions effectively leading to breast tumor growth and angiogenesis and which may have important therapeutic implications in management of breast cancer (Figure 8 ).
MATERIALS AND METHODS
Cell lines and transfections
Human breast cancer cells (MCF-7 and MDA-MB-231) were obtained from American Type Culture Collection. Stable transfectants using the full-length human OPN (OPN-a) in pCR3.1 (Dr. George F. Weber, University of Cincinnati) and OPN shRNA (Santa Cruz Biotechnology, Santa Cruz, CA, USA) were used for in vitro and in vivo experiments.
Hypoxia treatment
Hypoxia cultures were maintained in humidified 95% N 2 /5% CO 2 (o1% O 2 ) (Innova CO-170, New Brunswick Scientific, NJ, USA) or by flushing N 2 in Table 1 . Relationship between OPN and HIF1a expression in breast
Abbreviations: HIF, hypoxia-inducible factor; OPN, osteopontin. Billups-Rothenberg chamber (Billups-Rothenberg Inc., Del Mar, CA, USA) at 2 p.s.i. Cells were shifted to respective basal media before hypoxic exposure, and all hypoxia treatments were performed for 16 h unless specified. [56] [57] [58] Isolation of MEF cells E13.5 embryos from C57 WT and OPN KO mice were obtained and processed as described earlier. 59 (Sigma, St Louis, MO, USA) were used as previously described. 49 
RT-PCR
Western blot
The western blot was performed as described earlier. 60 ILK kinase assay ILK kinase activity was measured in MCF-7 or MCF-OPN-a cell lysates under different treatment conditions by immunoprecipitation in vitro kinase assay as previously described. 46 
Immunofluorescence
Immunofluorescence was carried out using specific antibodies as described earlier. 61 
Purification of human OPN
The human OPN was purified from breast milk as previously described. 61, 62 Wound migration, cell migration and invasion assays
The wound migration and cell migration assays using Transwell cell culture chamber were performed as described. 61 For invasion experiments, Transwells were coated with matrigel (BD Biosciences, San Jose, CA, USA) and experiments were performed as described. 61, 63 CAM assay MCF-7 or MCF-OPN-a cells under various treatment or transfection conditions were exposed to hypoxia, and conditioned media was collected, dialyzed and concentrated. The conditioned media was loaded onto uniform-sized gelatin sponge inserts, which was placed on the CAM of 4-day-old fertilized white leg horn eggs. On day 6, photographs were taken using stereo microscope attached with camera and the extent of vessel growth in comparison to day 4 was quantified using Angioquant software (Angioquant freeware; www.cs.tut.fi/sgn/csb/angioquant/).
In vivo tumorigenicity, immunohistochemistry and western blot
Briefly, MCF-7 or MCF-OPN-a cells (2 Â 10 6 ) were injected along with matrigel into lower right mammary fat pads of female NOD-SCID mice as described earlier. [64] [65] [66] The mice were kept in pathogen-free condition in the experimental animal facility of National Center for Cell Science (NCCS) as per institutional ethical guidelines. In separate experiments, MDA-MB-231 or MDA-MB-231 cells stably transfected with OPN shRNA (1 Â 10 6 ) were injected. Tumor size was recorded every week, and volumes were calculated using the following formula: (p/6(d1 Â d2) 3/2 )). At the end of 6 or 7 weeks, tumors were excised, photographed and weighted. Tumor growth kinetics was plotted as volume versus time and represented in the form of graph. Tumor sections or lysates were analyzed for expressions of various tumor angiogenesis-specific molecules using immunofluorescence and western blot.
Human breast cancer specimen analyses
Human breast cancer specimens (53 primary tumors, 8 fibroadenomas and 5 surrounding normal tissues) were collected from local hospital with informed consent. The specimens were analyzed by immunohistochemistry. The data analysis was performed using SPSS software (SPSS Inc., Chicago, IL, USA).
Statistical analysis
Statistical analysis was done by Student's t-test using Sigma Plot software (Systat Software Inc., San Jose, CA, USA). The statistical significance for observed difference was set at Po0.05. Wound migration analysis was performed using Image Pro Plus software (Nikon, Melville, NY, USA). Densitometry analysis was performed using NIH Image J software (Image J Freeware; http//rsb.info.nih.gov/ij/), and fold changes were calculated accordingly. 67 
